Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal - Sharps Technology (NASDAQ:STSS)

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic medications and 503B outsourcing that includes prefillable sterile syringes.

Related Keywords

South Carolina ,United States ,Hungary ,West Columbia ,America ,Sam Moghadam Khamseh ,Robert Hayes ,View Research ,Sharps Technology Inc ,Nephron Pharmaceuticals Corp ,Nephron Pharmaceuticals For Sharp ,Sharps Technology ,Asset Purchase Agreement ,Nephron Pharmaceuticals ,Manufacturing For ,Market Poised For ,Grand View ,Year Purchase Agreement ,Lampert Capital Advisors ,